Reclassification of gabapentin and pregabalin as CDs

Reclassification of gabapentin and pregabalin as CDs

March 26, 2019

Community pharmacy teams are reminded that from 1st April 2019 gabapentin and pregabalin will be reclassified as Schedule 3 Controlled Drugs (CDs).

Once this change has come into force, all gabapentin and pregabalin prescriptions will be subject to the prescription writing requirements for Schedule 3 CDs and it will be illegal to supply these drugs through repeat dispensing. However, pregabalin and gabapentin will be included in the list of “exempted drugs” in the Safe Custody Regulations which means that they will not be required to be kept in the CD cabinet.

We have updated our briefing to include information on NUMSAS and physiotherapist and podiatrist prescribing.

Questions relating to dispensing of CDs using EPS are covered in a separate briefing detailed below.

Guidance
PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs
PSNC Briefing 016/19: EPS Controlled drugs FAQs
NHS England has issued a briefing note on Rescheduling of Gabapentin and Pregabalin as Schedule 3 Controlled Drugs

 



Posted in: ,


More Latest News >

Shortage Notice: Salbutamol 2mg/5ml syrup

GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol...